| SC 13D/A | 2024-03-04 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 64,178,259 | 85.3% | EDGAR |
| SC 13G/A | 2024-02-14 | PUTNAM INVESTMENTS LLC | Innoviva, Inc. | 6,270,413 | 9.8% | EDGAR |
| SC 13G/A | 2024-02-13 | RENAISSANCE TECHNOLOGIES LLC | Innoviva, Inc. | 4,144,447 | 6.5% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Innoviva, Inc. | 6,712,443 | 10.5% | EDGAR |
| SC 13G | 2024-02-09 | DIMENSIONAL FUND ADVISORS LP | Innoviva, Inc. | 4,516,999 | 7.0% | EDGAR |
| SC 13G/A | 2024-01-22 | BlackRock Inc. | Innoviva, Inc. | 10,349,116 | 16.1% | EDGAR |
| SC 13D/A | 2023-07-11 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 64,178,259 | 85.3% | EDGAR |
| SC 13D/A | 2023-05-15 | Sarissa Capital Management LP | Innoviva, Inc. | 6,904,000 | 10.5% | EDGAR |
| SC 13G | 2023-02-14 | PUTNAM INVESTMENTS LLC | Innoviva, Inc. | 5,329,107 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-13 | RENAISSANCE TECHNOLOGIES LLC | Innoviva, Inc. | 4,229,607 | 6.1% | EDGAR |
| SC 13G/A | 2023-02-10 | BlackRock Inc. | Innoviva, Inc. | 10,611,839 | 15.2% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Innoviva, Inc. | 7,072,212 | 10.1% | EDGAR |
| SC 13G/A | 2023-02-02 | WESTFIELD CAPITAL MANAGEMENT CO LP | Innoviva, Inc. | 4,106,136 | 5.9% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | Innoviva, Inc. | 5,671,100 | 10.6% | EDGAR |
| SC 13G | 2023-01-20 | BlackRock Inc. | Innoviva, Inc. | 5,671,100 | 10.6% | EDGAR |
| SC 13D/A | 2023-01-10 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 64,178,259 | 85.3% | EDGAR |
| SC 13D/A | 2022-07-11 | Innoviva, Inc. | Entasis Therapeutics Holdings Inc. | 100 | 100.0% | EDGAR |
| SC 13G/A | 2022-07-11 | VANGUARD GROUP INC | Innoviva, Inc. | 6,970,950 | 10.0% | EDGAR |
| SC 13D/A | 2022-05-24 | Innoviva, Inc. | Entasis Therapeutics Holdings Inc. | 57,345,794 | 74.9% | EDGAR |
| SC 13D/A | 2022-04-01 | Innoviva, Inc. | Armata Pharmaceuticals, Inc. | 44,441,416 | 80.1% | EDGAR |